MRI-guided SBRT reduces side effects in prostate cancer treatment

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality of life, particularly in bowel and sexual health, compared to conventional CT-guided treatment.

As cash runs tight, bluebird plunges after pricing sickle cell gene therapy well above competitor and failing to win review voucher

Investors reacted negatively to bluebird bio’s pricing plans for its new sickle cell therapy, as well as the lack of a valuable priority review voucher

December 9, 2023

FDA OKs First Point-of-Care Test for Detecting Hep C in At-Risk Adults

The FDA on Thursday granted marketing authorization to the first point-of-care test for hepatitis C virus (HCV), enabling at-risk adults to be rapidly diagnosed and

June 28, 2024

CDC Journal Resumes Publication, but Without H5N1 Studies

The CDC’s Morbidity and Mortality Weekly Report (MMWR) resumed publishing after an unprecedented 2-week hiatus, but without the three H5N1 avian influenza papers that were

February 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.